Abstract

High fat diet-induced changes in gut microbiota have been linked to intestinal permeability and metabolic endotoxemia, which is related to metabolic disorders. However, the influence of a high-glucose (HGD) or high-fructose (HFrD) diet on gut microbiota is largely unknown. We performed changes of gut microbiota in HGD- or HFrD-fed C57BL/6J mice by 16S rRNA analysis. Gut microbiota-derived endotoxin-induced metabolic disorders were evaluated by glucose and insulin tolerance test, gut permeability, Western blot and histological analysis. We found that the HGD and HFrD groups had comparatively higher blood glucose and endotoxin levels, fat mass, dyslipidemia, and glucose intolerance without changes in bodyweight. The HGD- and HFrD-fed mice lost gut microbial diversity, characterized by a lower proportion of Bacteroidetes and a markedly increased proportion of Proteobacteria. Moreover, the HGD and HFrD groups had increased gut permeability due to alterations to the tight junction proteins caused by gut inflammation. Hepatic inflammation and lipid accumulation were also markedly increased in the HGD and HFrD groups. High levels of glucose or fructose in the diet regulate the gut microbiota and increase intestinal permeability, which precedes the development of metabolic endotoxemia, inflammation, and lipid accumulation, ultimately leading to hepatic steatosis and normal-weight obesity.

Highlights

  • Obesity is recognized as a global public health issue, as its prevalence is consistently increasing in most countries [1]

  • high-fat diet (HFD)-induced inflammation and metabolic disorders are the context of metabolic disorders

  • We observed increased Firmicutes-to-Bacteroidetes ratios and widespread changes in gut microbial communities, including increased proportions of Proteobacteria and decreased proportions of Actinobacteria in the HFD, high-glucose diet (HGD), and high-fructose diet (HFrD) groups compared to in the normal diet (ND) group. These results indicate that the HGD and HFrD, as well as the HFD, modulate gut microbiota and cause gut microbiota-induced inflammation and fatty liver

Read more

Summary

Introduction

Obesity is recognized as a global public health issue, as its prevalence is consistently increasing in most countries [1]. One of the metabolic disorders, obesity, plays an important role in pathogenesis of chronic diseases and is characterized by low-grade inflammation [2]. Overconsumption of sugar is closely linked to obesity and metabolic disease [5]. The treatment of obesity and its complications has become a major public health focus, and novel treatment strategies would be highly beneficial. The microbial community within the gut has been linked with several metabolic diseases, including diabetes, non-alcoholic fatty liver disease, cardiovascular disease, and obesity [6,7]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call